Sight Sciences announced the United States launch of the Ergo-Series of the OMNI Surgical System, a technology that facilitates surgeons’ ability to perform minimally invasive, implant-free glaucoma procedures in adults with primary open-angle glaucoma. The OMNI Surgical System enables a minimally invasive glaucoma surgery that addresses all three known points of resistance in the aqueous outflow system: the trabecular meshwork, Schlemm’s canal, and the collector channels. It can be used before, in combination with, or following cataract surgery. The new features of the Ergo-Series include: Improved Handle Ergonomics: New enhancements enable surgeons to more easily rotate and position the cannula tip within Schlemm’s canal with precise finger rotations versus wrist adjustments. Simplified Viscoelastic Preparation: The handle’s viscoelastic luer connector is now removable and detaches when the viscoelastic cartridge is removed, resulting in more clearance with the surgical microscope. New Cannula Tip Design: The Ergo-Series cannula tip has a new profile that enables gentle and precise access to Schlemm’s canal while continuing to enable full 360-degree catheterization associated with the OMNI procedure. The Ergo-Series of the OMNI Surgical System is expected to be available outside the United States later this year.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SGHT: